Medical device and healthcare company Abbott arranged to have their canine and kid patients treated for patent ductus arteriosus meet in Los Angeles ...
Results reinforce that Amplatzer Piccolo™ Occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (PDA) in newborns Study found low adverse event rates ...
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system enables precise ...
Abbott announced the US Food and Drug Administration (FDA) approved the Amplatzer Piccolo Occluder, the world's first medical device that can be implanted in the tiniest babies (weighing as little as ...
Dr. Saar Danon recently conducted MCWHLB’s 10th PDA device closure in premature babies with the piccolo device (the device is a size of a pea) and is the best intervention for babies with PCA who are ...
The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), the first medical device to treat patent ductus arteriosus (PDA) in premature babies weighing as little ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results